[A new classification of prophylactic antiradiation agents]

Area of Science:

• Pharmacology and Toxicology
• Radiation Biology
• Nuclear Medicine

Context:

• Development of effective countermeasures against ionizing radiation exposure is critical for military personnel, astronauts, and civilian populations.
• Existing prophylactic antiradiation drugs lack a unified classification system, hindering optimal selection and application.
• Understanding the differential properties of various radioprotective agents is essential for comprehensive radiation safety strategies.

Purpose:

• To propose a novel classification system for prophylactic antiradiation drugs.
• To delineate the distinct characteristics and mechanisms of action for radioprotectors, radioresistance stimulators, and agents for internal irradiation protection.
• To provide a framework for evaluating the efficacy and application of these agents in different radiation exposure scenarios.

Summary:

• The proposed classification divides drugs into three main groups: radioprotectors (myelo-, entero-, cerebroprotectors), stimulators of radioresistance (single/repeated use), and agents for internal irradiation protection (thyroid/digestive tract).
• Radioprotectors offer rapid, short-term protection against acute irradiation but have limitations with repeated use and toxicity.
• Stimulators of radioresistance provide prolonged protection against chronic, low-dose irradiation with lower toxicity and reduced delayed effects, suitable for both prophylactic and therapeutic use.

Impact:

• This classification provides a structured approach to understanding and utilizing antiradiation drugs.
• It facilitates the selection of appropriate agents based on the type, duration, and scenario of radiation exposure.
• The framework supports the development of optimized radiation protection strategies for diverse populations and applications.